Summary of Purpose
Ischemic stroke is accompanied by a three to four hundred percent increase in the brain's extracellular fluid (ECF) and cerebrospinal fluid (CSF) concentration of glutamate, which diffuses and damages surrounding neurons. In this study we tested our hypothesis that blood glutamate levels can be reduced by hemofiltration, resulting in increased extracellular clearance of glutamate and attenuated neurodegeneration,...Read More →
The following dates are available for this trial. Trial information last updated on 5 March 2018.
|1 Jun 2014||16 Feb 2018||31 Jan 2015||31 Jan 2015||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|